Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.075 EUR | +2.50% | +2.97% | -16.58% |
Mar. 27 | Heidelberg Pharma Wins US FDA Orphan Drug Designation for Multiple Myeloma Treatment | MT |
Mar. 25 | Transcript : Heidelberg Pharma AG, 2023 Earnings Call, Mar 25, 2024 |
- Stock Market
- Equities
- HPHA Stock
- News Heidelberg Pharma AG